OBJECTIVE Mutations of the GNAS1 gene, which is located on chromosome
20q13.11 and encodes the alpha-subunit of the stimulatory GTP-binding
protein, have been identified in patients with pseudohypoparathyroidis
m type Ia (PHPIa) and pseudopseudohypoparathyroidism (PPHP), We have u
ndertaken studies to determine the prevalence of GNAS1 mutations and t
o explore methods for their more rapid detection. METHODS Thirteen unr
elated families (8 with PHPIa and PPHP patients, and 5 with PPHP patie
nts only) were investigated for GNAS1 mutations in the 1050 base-pair
(bp) region spanning exons 2-13 by single-stranded conformational poly
morphism (SSCP) and DNA sequence analysis, RESULTS GNAS1 mutations wer
e detected in 4 of the 8 families with PHPIa patients. These consisted
of: two novel de novo missense mutations (Pro115Ser and Glu259Val) in
two families and an identical 4 bp deletion of codons 189 and 190 res
ulting in a frameshift in two unrelated families. These results expand
the spectrum of GNAS1 mutations associated with this disorder and con
firm the presence of a mutational hot-spot involving codons 189 and 19
0, SSCP analysis was found to be a specific and sensitive method that
detected all 4 mutations, GNAS1 mutations were not detected in any of
the PPHP only families. CONCLUSIONS The pseudohypoparathyroid disorder
s appear to represent a heterogeneous group with GNAS1 mutations formi
ng the molecular aetiology in approximately 50% of pseudohypoparathyro
idism type la families. Such mutations can be reliably identified by s
ingle-stranded conformational polymorphism and this will help to suppl
ement the clinical evaluation of some patients and their families, par
ticularly as the disease may not be fully penetrant.